Synpromics' Private Equity Round

Synpromics raised a round of funding on August 17, 2015. Investors include Calculus Capital.

Synpromics is a developer of synthetic gene promoters, which are vital components in the research and development of gene-based medical treatments and therapies. Synpromics gives biological researcher…

Articles about Synpromics' Private Equity Round: